ViaCyte Competitors and Similar CompaniesClear all
ViaCyte's competitors and similar companies include Profil, Kerecis and Fractyl Health.
 ViaCyte ViaCyte is a regenerative medicine company focused on developing a novel cell therapy for the treatment of diabetes. |  Profil Profil Institut für Stoffwechselforschung is a clinical research organisation for studies related to diabetes and obesity. |  Kerecis Kerecis develops, manufactures and markets patented Omega3 rich fish skin, in skin and tissue repair. |  Fractyl Health Fractyl Health (formerly known as Fractyl Laboratories) is a metabolic therapeutics company that develops therapies for treating type 2 diabetes (T2D) and obesity. | |
Founding Date | Founding Date 1999 | Founding Date 1999 | Founding Date 2011 | Founding Date 2010 |
Type | Type Private | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations San Diego, US HQ | Locations Neuss, DE HQ Mainz, DE | Locations Arlington, US HQ Ísafjörður, IS Reykjavík, IS Reykjavík, IS | Locations Burlington, US HQ |
Employees | Employees 176% decrease | Employees 200 | Employees 512 | Employees 88 |
Funding | ||||
Latest funding round | Latest funding round $ 45m (almost 5 years ago) | Latest funding round N/A | Latest funding round $ 16m (almost 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 246.9m | Total funding raised N/A | Total funding raised $ 27.6m | Total funding raised $ 190.1m |
For sources of this data, please see the company profile
View Company Profiles
Profil
HQ
Neuss, DE
Employees
200
Profil Institut für Stoffwechselforschung is a clinical research organisation for studies related to diabetes and obesity.
View companyKerecis
HQ
Arlington, US
Employees
512
Kerecis develops, manufactures and markets patented Omega3 rich fish skin, in skin and tissue repair.
View companyFractyl Health
HQ
Burlington, US
Employees
88
Fractyl Health (formerly known as Fractyl Laboratories) is a metabolic therapeutics company that develops therapies for treating type 2 diabetes (T2D) and obesity.
View company